Washington Drug Letter
Aug. 6, 2012
| Vol.
44 No.
31
FDA Lays Out Fiscal 2013 User Fee Rates for PDUFA, BSUFA
Drugmakers must dole out nearly $2 million in fees for drug applications requiring clinical data in fiscal 2013, while companies submitting applications without such data, or supplemental drug apps, will need to fork over half that amount.
This article is viewable by subscribers only. To view this article, please select an option below.
|